These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 15351100)

  • 21. The effect of medroxyprogesterone acetate on estrogen-dependent risks and benefits--an attempt to interpret the Women's Health Initiative results.
    Kuhl H; Stevenson J
    Gynecol Endocrinol; 2006 Jun; 22(6):303-17. PubMed ID: 16785155
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Breast cancer risk in the WHI study: the problem of obesity.
    Kuhl H
    Maturitas; 2005 May; 51(1):83-97. PubMed ID: 15883113
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Is the clinical profile of women treated with tibolone similar to that of women receiving a classical estrogen-progestogen therapy? Data from a nationwide survey in France].
    Jamin C; Bourg F; Legeai J; Senoussi S
    Gynecol Obstet Fertil; 2006 Mar; 34(3):224-32. PubMed ID: 16513401
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is HRT justified for symptom management in women at higher risk of developing breast cancer?
    Rippy L; Marsden J
    Climacteric; 2006 Dec; 9(6):404-15. PubMed ID: 17085372
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Progestogen use in women approaching the menopause and breast cancer risk.
    Campagnoli C; Ambroggio S; Lotano MR; Peris C
    Maturitas; 2009 Apr; 62(4):338-42. PubMed ID: 19118958
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of progesterone, testosterone and synthetic progestogens on growth factor- and estradiol-treated human cancerous and benign breast cells.
    Krämer EA; Seeger H; Krämer B; Wallwiener D; Mueck AO
    Eur J Obstet Gynecol Reprod Biol; 2006 Nov; 129(1):77-83. PubMed ID: 16460873
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ovarian steroids influence cell proliferation in the dentate gyrus of the adult female rat in a dose- and time-dependent manner.
    Tanapat P; Hastings NB; Gould E
    J Comp Neurol; 2005 Jan; 481(3):252-65. PubMed ID: 15593136
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Breast cancer and hormonal therapy.
    Conner P; Lundström E; von Schoultz B
    Clin Obstet Gynecol; 2008 Sep; 51(3):592-606. PubMed ID: 18677153
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of different HRT regimens on mammographic density.
    Junkermann H; von Holst T; Lang E; Rakov V
    Maturitas; 2005 Feb; 50(2):105-10. PubMed ID: 15653007
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Moderate dosage estrogen-androgen therapy improves continuation rates in postmenopausal women: impact of the WHI reports.
    Gambrell RD; Natrajan PK
    Climacteric; 2006 Jun; 9(3):224-33. PubMed ID: 16766436
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Digitized assessment of mammographic breast density in patients who received low-dose intrauterine levonorgestrel in continuous combination with oral estradiol valerate: a pilot study.
    Lundström E; Söderqvist G; Svane G; Azavedo E; Olovsson M; Skoog L; von Schoultz E; von Schoultz B
    Fertil Steril; 2006 Apr; 85(4):989-95. PubMed ID: 16580385
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Type and duration of exogenous hormone use affects breast cancer histology.
    Kumar AS; Cureton E; Shim V; Sakata T; Moore DH; Benz CC; Esserman LJ; Hwang ES
    Ann Surg Oncol; 2007 Feb; 14(2):695-703. PubMed ID: 17103262
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of hormone replacement therapy regimens on mammographic breast density: the role of progestins.
    Topal NB; Ayhan S; Topal U; Bilgin T
    J Obstet Gynaecol Res; 2006 Jun; 32(3):305-8. PubMed ID: 16764621
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recent insight on the control of enzymes involved in estrogen formation and transformation in human breast cancer.
    Pasqualini JR; Chetrite GS
    J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):221-36. PubMed ID: 15860265
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cancer issues.
    Marsden J; Sturdee D
    Best Pract Res Clin Obstet Gynaecol; 2009 Feb; 23(1):87-107. PubMed ID: 19036643
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Breast density: a major parameter to follow during hormone replacement therapy].
    Gairard B; Guldenfels C; Haehnel P; Mathelin C
    Gynecol Obstet Fertil; 2009; 37(7-8):657-60. PubMed ID: 19577502
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Breast cancer and sex steroids: critical review of epidemiological, experimental and clinical investigations on etiopathogenesis, chemoprevention and endocrine treatment of breast cancer.
    Gadducci A; Biglia N; Sismondi P; Genazzani AR
    Gynecol Endocrinol; 2005 Jun; 20(6):343-60. PubMed ID: 16019385
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Estrogen and combined estrogen-progestogen therapy in the menopause and breast cancer.
    La Vecchia C
    Breast; 2004 Dec; 13(6):515-8. PubMed ID: 15563861
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Androgens, estrogens, and mammary epithelial proliferation.
    Longcope C
    Menopause; 2003; 10(4):274-6. PubMed ID: 12851509
    [No Abstract]   [Full Text] [Related]  

  • 40. Parallel assessment of the impact of different hormone replacement therapies on breast density by radiologist- and computer-based analyses of mammograms.
    Pettersen PC; Raundahl J; Loog M; Nielsen M; Tankó LB; Christiansen C
    Climacteric; 2008 Apr; 11(2):135-43. PubMed ID: 18365856
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.